Log In
Saturday 24th August 2019

Risk of skin cancer from biologic therapies

12th September 2011

Scientists from Imperial College, Leeds University and other European universities have found the danger of skin cancer could be increased by biologic therapies.

The team reviewed 21 studies and eight conference abstracts which involved over 40,000 patients. The study's authors, whose work was published in the Annals of the Rheumatic Diseases, wrote: "This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma." 

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019